Events

  • Symposium Growth Factors and Cell Transformation

    Register for the Growth Factors and Cell Transformation (GFCT) symposium at Rudbeck Laboratory in Uppsala, May 30, 2012. An international symposium that will focus on growth factor signaling and tu...
  • AIMday® Cancer 2012

    On June 12, 2012, the event AIMday® Cancer will be organised again. The meeting is arranged by UU Innovation and the overall aim is to link queries and needs of companies and public authorities with a...
  • ...

Up-coming dissertations

  • Friday, May 25, 2012 09:15 Rudbecksalen, Dag Hammarskjölds väg 20, Uppsala Zieba, Agata Application of Proximity Ligation Assay for Multidirectional Studies on Transforming Growth Factor-β Pathway [Free fulltext] [More information]
  • Wednesday, May 30, 2012 09:15 Fåhreussalen, Rudbecklaboratoriet, Dag Hammarskjölds V. 20, Uppsala Skog, Oskar Effects of Enterovirus Infection on Innate Immunity and Beta Cell Function in Human Islets of Langerhans [Free fulltext] [More information]

Rudbeck exterior

 

Welcome to IGP

The department conducts advanced research and education in areas such as clinical immunology, medical and clinical genetics, pathology, tumor biology and vascular biology. Part of the work is done in collaboration with the units of clinical genetics, clinical pathology-cytology and clinical immunology at Uppsala University Hospital.


Clinical genetics
Clinical pathology and cytology
Clinical immunology and transfusion medicine

 

New research findings from IGP

  • Time and location important for childhood brain tumors

    Does it matter which part of the brain a tumor originates from? Is it important to determine how young a patient was when the cancer started? IGP researcher Fredrik Swartling has in collaboration with researchers from USA, Canada and England shown that childhood brain tumors preserve certain characteristics that are present in the normal cell from which they originated.

  • New technique improves analyses of the tumor disease chronic lymphocytic leukemia

    Chronic lymphocytic leukemia is a tumor disease with varying progression. Many patients can live for a long time with their disease while others rapidly deteriorate. Researchers in the groups of Richard Rosenquist and Ulf Gyllensten have used a new sequencing technique to study and compare genetic alterations in groups of patients with different prognosis. The results showed that the technique can be used to study chronic lymphocytic leukemia in ways previously not possible.

  • Genetic adaptation of fat metabolism key to development of the human brain

    The fatty acids omega-3 and omega-6 are essential for the development and function of the human brain. In a recent study led by researchers at IGP it was found that during evolution humans have been genetically adapted to more efficiently synthesize omega-3 and omega-6 from fatty acids in vegetable oils. This adaptation would have been an advantage in situations with a limited supply of food with omega-3 and omega-6. Today, it can instead be associated with an increased risk for coronary artery disease

Gå till RSS

News

  • Research grant to Bo Nilsson

    Bo Nilsson has received a grant of 3.6 million SEK from the insurance company AFA Försäkring, for a project focusing on how nano particles affect the immune response.

  • Large grant to Ulf Gyllensten and Uppsala Genome Center

    Ulf Gyllensten has, together with Joakim Lundeberg at KTH, been awarded a grant of 57.8 million SEK from the Knut and Alice Wallenberg Foundation. The grant will be used for genome sequencing equipment at SciLifeLab’s sequencing platforms in Uppsala and Stockholm.

  • Niklas Dahl awarded for patient oriented research

    Niklas Dahl has received the Uppsala County Council research prize for his research on genetic alterations associated with heritable diseases.